Metronidazole La Colina

Metronidazole, the active ingredient in Metronidazole La Colina, is a nitroimidazole antibiotic presented as an oral dosage form for systemic use. It treats infections caused by anaerobic bacteria and certain protozoa in adults and children as directed by a healthcare professional.

GNH USA supplies Metronidazole La Colina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is a nitroimidazole agent that targets anaerobic bacteria and protozoal organisms. It is employed in several well‑established clinical situations: - Bacterial vaginosis: restores normal vaginal flora by eradicating anaerobic pathogens. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Amoebiasis: clears intestinal Entamoeba histolytica infection and associated liver abscesses. - Anaerobic bacterial infections (intra‑abdominal, pelvic, skin and soft‑tissue): provides bactericidal activity against mixed anaerobic flora. - Clostridioides difficile infection (adjunct therapy): reduces toxin‑producing bacterial load when used with standard therapy.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Diarrhea: loose stools that may be watery. - Abdominal pain: cramping or discomfort in the stomach area. - Headache: mild to moderate headache. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Seizures: convulsions, particularly with high doses or rapid infusion. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, swelling, anaphylaxis. - Stevens‑Johnson syndrome: severe skin blistering and detachment. - Hepatitis: liver inflammation with jaundice. - Neutropenia: marked reduction in white blood cells.

Before initiating therapy, clinicians should consider several safety aspects. - Assess renal function: dose adjustment may be needed in renal impairment. - Monitor hepatic function: avoid use in severe liver disease. - Avoid alcohol: risk of disulfiram‑like reaction. - Use caution in pregnancy: only if benefits outweigh potential risks. - Use caution in patients with CNS disorders: may lower seizure threshold. - Store at room temperature: keep in the original pack, protect from moisture.

Metronidazole can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce hormonal efficacy, consider backup method. - Cimetidine: can increase metronidazole plasma concentrations. - Carbamazepine: may lower metronidazole levels, reducing therapeutic effect.